You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 121 No. 6, June 2003 TABLE OF CONTENTS
  Archives
  •  Online Features
  Clinicopathologic Reports, Case Reports, and Small Case Series
 This Article
 •Extract
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on ISI (1)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •External Eye Disease
 •Dermatology
 •Herpes
 •Alert me on articles by topic

Herpes Simplex Virus Dacryoadenitis in an Immunocompromised Patient

Arch Ophthalmol. 2003;121:911-913.

Infections of the lacrimal gland are uncommon and can be divided into 2 major classes: acute suppurative dacryoadenitis and chronic dacryoadenitis. Acute suppurative dacryoadenitis is usually bacterial in origin, commonly caused by Staphylococcus,1 with Streptococcus, Chlamydia trachomatis, and Neisseria gonorrhoeae as other possible causes. Chronic dacryoadenitis is more slowly progressive and often caused by viruses, particularly the mumps virus. Other reported causes of dacryoadenitis include Epstein-Barr virus,2-3 pneumococci, diphtheria, syphilis, actinomycosis, histoplasmosis, trachoma, tuberculosis, typhoid, brucellosis, mononucleosis, measles, cytomegalovirus, coxsackievirus, echoviruses, and varicella-zoster virus.4 We describe an unusual case of an immunocompromised patient with dacryoadenitis caused by the herpes simplex virus (HSV).

Report of a Case

A 29-year-old man developed acute right upper eyelid tenderness, ptosis, and edema associated with an enlarged and indurated lacrimal gland. Marked conjunctival chemosis was present and ocular motility was mildly limited (Figure 1). The right preauricular node was both tender and palpable. The patient's history was significant for acquired immunodeficiency syndrome, intolerant to highly active antiretroviral therapy. He was not taking antiretroviral therapy at the time of examination. He had previously been treated for syphilis and herpes zoster localized to the back and left lower extremity. His temperature was 37.5°C. Visual acuity was 20/40 OD and 20/20 OS. Ophthalmoscopy showed cotton-wool spots and dot-blot hemorrhages consistent with mild, bilateral retinopathy caused by human immunodeficiency virus. Orbital computed tomographic scan was notable for bilaterally enlarged lacrimal glands and diffuse right preseptal soft-tissue swelling (Figure 2).



View larger version (73K):
[in this window]
[in a new window]
Figure 1. Acute right orbital inflammation secondary to herpes simplex virus dacryoadenitis.




View larger version (41K):
[in this window]
[in a new window]
Figure 2. Computed tomographic scan of the orbits. Both lacrimal glands are enlarged.


Routine bacterial and fungal blood cultures were negative, as were routine bacterial and fungal conjunctival cultures. Because of allergies to penicillin and sulfa drugs, the patient was started on a regimen of clindamycin and ciprofloxacin hydrochloride. During the next 10 days, his condition worsened and the right orbital inflammation increased. A diagnostic right lacrimal gland biopsy was performed.

At surgery, the gland appeared indurated, without evidence of abscess. Cultures were obtained. Aerobic, anaerobic, acid-fast bacterial, and fungal cultures were negative. Interestingly, the conventional tube culture, derived from grinding the tissue obtained by biopsy and culturing on cell lines, was positive for adenovirus but negative for cytomegalovirus, HSV, varicella-zoster virus, and enterovirus. Histologic sections of the lacrimal gland biopsy specimen documented the presence of a necrotizing dacryoadenitis, with a dense infiltrate composed of neutrophils; histiocytes; small, cytologically bland lymphocytes;and lesser numbers of plasma cells and eosinophils. This infiltrate was associated with extensive glandular destruction (Figure 3). The viral cytopathic change typical of adenovirus infection—amphophilic inclusions with peripheral clearing or "smudge cells"—was not identified. Immunoperoxidase studies performed on paraffin-embedded material with standard methods and commercially available antibodies (HSV-1 and -2, DAKO Corp, Carpinteria, Calif, polyclonal, product ID B0114, 1:250; cytomegalovirus, DAKO Corp, clone DDG9 and CCH2 cocktail, 1:25; adenovirus, Research Diagnostics Inc, Flanders, NJ, clone M58 and M73 cocktail, 1:50) were positive for HSV (Figure 4) and negative for cytomegalovirus and adenovirus. Flow cytometric analysis of the lymphoid component identified a dominant population of reactive CD3+ T cells, with negligible numbers of reactive CD19+ B cells. When taken together, the morphologic finding of inclusions, the positive immunostain results, and the negative lymphoma workup (flow cytometery) all supported the diagnosis of herpetic dacryoadenitis.



View larger version (137K):
[in this window]
[in a new window]
Figure 3. The lacrimal gland architecture is markedly distorted by a mixed neutrophilic, lymphocytic, and histiocytic infiltrate. Epithelial cells contain nuclear inclusions typical of herpes simplex infection (arrows) (hematoxylin-eosin, original magnification x200).




View larger version (139K):
[in this window]
[in a new window]
Figure 4. Immunohistochemical studies demonstrate a strong nuclear positivity for herpes simplex virus. Because of the targeted epitope, distinction between herpes simplex viruses 1 and 2 is not possible by this method (herpes simplex virus immunohistochemistry stain, avidin-biotin complex method, original magnification x400).


Given the diagnosis of HSV dacryoadenitis, the patient started treatment with acyclovir (10 mg/kg administered intravenously every 8 hours). He responded within 5 days and was discharged from the hospital on a regimen of erythromycin ophthalmic ointment and famciclovir, 500 mg by mouth 3 times a day. He made an uneventful recovery with the exception of bilateral mild dry eye symptoms. The patient was lost to follow-up before a posttreatment Schirmer test could be performed.


Comment

The discordant pathology immunophenotypic results and culture results may relate to 1 of 2 possibilities. First, immunostains do not have 100% sensitivity, and the patient's dacryoadenitis may be due to both HSV and adenovirus infection. The absence of viral inclusions and pathologic changes characteristic of adenovirus5 make this possibility unlikely. Second, the patient may have had active necrotizing dacryoadenitis caused by HSV, with cultures positive for adenovirus because of latent adenovirus harbored in lacrimal gland tissue. We favor this latter possibility, because the pathological evaluation failed to disclose evidence of direct tissue damage caused by adenovirus and the patient responded to acyclovir therapy. In addition, a review of the literature6-7 shows that the rate of false-negative culture results for HSV, when compared with polymerase chain reaction, ranges from 57% to 78%. Finally, ocular swabs and nasopharyngeal swabs 3 months after admission, performed by the patient's internal medicine physician after the patient's ophthalmic findings had resolved, were positive for adenovirus.

This case illustrates the possibility that herpesviruses can cause dacryoadenitis without corneal involvement and that HSV is a potential pathogen for immunocompromised patients with dacryoadenitis. It is unclear whether the lacrimal gland was the primary site of infection, since there was a coexisting conjunctival reaction. It is possible that the gland became secondarily infected from a primary herpetic conjunctivitis.8 Zarrabi9 reported 2 cases of dacryoadenitis in nonimmunocompromised patients with corneal dendrites. While these patients may have had HSV dacryoadenitis, confirmatory cultures and biopsies were not performed.

Empirical antiviral therapy should be considered in patients with atypical dacryoadenitis. Lacrimal gland biopsy and immunoperoxidase staining are helpful in confirming the cause of this condition.


AUTHOR INFORMATION

William J. Foster, Jr, MD, PhD; Madeleine D. Kraus, MD; Philip L. Custer, MD
St Louis, Mo

Corresponding author: William J. Foster, Jr, MD, PhD, Department of Ophthalmology and Visual Sciences, Washington University School of Medicine, Campus Box 8096, 660 S Euclid Ave, St Louis, MO 63110-1093 (address beginning July 1, 2003: Jules Stein Eye Institute, 100 Stein Plaza, UCLA, Los Angeles, CA 90095).


REFERENCES

1. Boruchoff SA, Boruchoff SE. Infections of the lacrimal system. Infect Dis Clin North Am. 1992;6:925-932. ISI | PUBMED
2. Merayo-Lloves J, Baltatzis S, Foster C. Epstein-Barr virus dacryoadenitis resulting in keratoconjunctivitis sicca in a child. Am J Ophthalmol. 2001;132:922-923. PUBMED
3. Aburn N, Sullivan T. Infectious mononucleosis presenting with dacryoadenitis. Ophthalmology. 1996;103:776-778. ISI | PUBMED
4. Duke-Elder S, MacFaul P. The ocular adnexa. In: System of Ophthalmology. St Louis, Mo: Mosby; 1974:601-620.
5. Wood R, Trousdale M, Stevenson D, Azzarolo A, Mircheff A. Adenovirus infection of the cornea causes histopathologic changes in the lacrimal gland. Curr Eye Res. 1997;16:459-466. FULL TEXT | ISI | PUBMED
6. Koenig M, Reynolds K, Aldous W, Hickman M. Comparison of Light-cycler PCR, enzyme immunoassay, and tissue culture for detection of herpes simplex virus. Diagn Microbiol Infect Dis. 2001;40:107-110. FULL TEXT | ISI | PUBMED
7. Burrows J, Nitsche A, Bayly B, Walker E, Higgins G, Kok T. Detection and subtyping of Herpes simplex virus in clinical samples by LightCycler PCR, enzyme immunoassay and cell culture. BMC Microbiol. 2002;2:12-18. FULL TEXT | PUBMED
8. Jones B. The clinical features and aetiology of dacryoadenitis. Trans Ophthalmol Soc U K. 1955;75:435-453.
9. Zarrabi M. Deux cas de dacryoadénite aiguë avec kératite dendritique. Arch Ophtalmol (Paris). 1958;18:57.

SECTION EDITOR: W. RICHARD GREEN, MD







HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2003 American Medical Association. All Rights Reserved.